Oral Squamous Cell Carcinoma
New oral squamous cell carcinoma findings from National Institutes of Health published
Published in Oncology Business Week, May 3rd, 2009
According to recent research published in the International Journal of Cancer, "Interleukin-13 receptor-targeted cytotoxin (IL13-PE38) is highly cytotoxic to certain types of human cancers expressing abundant levels of IL-13R alpha 2 chain. Although IL13-PE38 is being tested in a Phase III clinical trial in brain tumors, the activity of IL13-PE38 alone or when combined with taxane, a chemotherapeutic drug for oral squamous cell carcinoma (OSCC), has not been investigated."
"Here, we show that approximately 40% of OSCCs (n = 150) in a tissue array are strongly positive for IL-13R alpha 2, whereas normal oral mucosa (n = 10) expresses very low or undetectable...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Oncology Business Week
More Articles from Oncology Business Week
- Allergies
VentiRx Pharmaceuticals Initiates Phase I Clinical Trial of VTX-1463, a Novel TLR8 Agonist for the Treatment of Allergic Rhinitis - Amerinet Inc.
Amerinet Member Conference to Focus on Key Industry Issues - Bioscience
Cell Biosciences Launches Next-Generation Protein Characterization System - Biotechnology
EMD Serono President and CEO Fereydoun Firouz Honored by Massachusetts Biotechnology Council with its 2009 Innovative Leadership Award - Biotechnology Business
AEterna Zentaris To Present Data on Anticancer Compounds AEZS-112 and AEZS-126 at AACR Annual Meeting - Biotechnology Business
Bio-rad Launches Bio-plex Pro Magnetic Bead-based Human and Mouse Cytokine Assays - More from this issue of Oncology Business Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
